Ataxxa 500 mg/100 mg spot-on solution for dogs over 4 kg up to 10 kg
Ataxxa 500 mg/100 mg spot-on solution for dogs over 4 kg up to 10 kg
Authorised
- Permethrin
- Imidacloprid
Product identification
Medicine name:
Ataxxa 500 mg/100 mg spot-on solution for dogs over 4 kg up to 10 kg
Ataxxa 500 mg - 100 mg Spot-on oplossing
Ataxxa 500 mg - 100 mg Solution pour spot-on
Ataxxa 500 mg - 100 mg Lösung zum Auftropfen
Active substance:
- Permethrin
- Imidacloprid
Target species:
-
Dog
Route of administration:
-
Spot-on use
Product details
Active substance and strength:
-
Permethrin500.00/milligram(s)1.00Pipette
-
Imidacloprid100.00/milligram(s)1.00Pipette
Pharmaceutical form:
-
Spot-on solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP53AC54
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Available in:
-
Belgium
Package description:
- White polypropylene pipette closed with a polyoxymethylene cap. Each pipette is packed in apolyethylene terephthalate/aluminium/low density polyethylene triplex bag.3 ml pipette containing 1 ml of solution.Box containing 10 pipettes.
- White polypropylene pipette closed with a polyethylene cap. Each pipette is packed in apolyethylene terephthalate/aluminium/low density polyethylene triplex bag.3 ml pipette containing 1 ml of solution.Box containing 6 pipettes.
- White polypropylene pipette closed with a polyethylene cap. Each pipette is packed in apolyethylene terephthalate/aluminium/low density polyethylene triplex bag.3 ml pipette containing 1 ml of solution.Box containing 4 pipettes.
- White polypropylene pipette closed with a polyoxymethylene cap. Each pipette is packed in apolyethylene terephthalate/aluminium/low density polyethylene triplex bag.3 ml pipette containing 1 ml of solution.Box containing 3 pipettes.
- White polypropylene pipette closed with a polyethylene cap. Each pipette is packed in apolyethylene terephthalate/aluminium/low density polyethylene triplex bag.3 ml pipette containing 1 ml of solution.Box containing 1 pipette.
- White polypropylene pipette closed with a polyethylene cap. Each pipette is packed in apolyethylene terephthalate/aluminium/low density polyethylene triplex bag.3 ml pipette containing 1 ml of solution.Box containing 10 pipettes.
- White polypropylene pipette closed with a polyoxymethylene cap. Each pipette is packed in apolyethylene terephthalate/aluminium/low density polyethylene triplex bag.3 ml pipette containing 1 ml of solution.Box containing 6 pipettes.
- White polypropylene pipette closed with a polyoxymethylene cap. Each pipette is packed in a polyethylene terephthalate/aluminium/low density polyethylene triplex bag. 3 ml pipette containing 1 ml of solution. Box containing 4 pipettes.
- White polypropylene pipette closed with a polyoxymethylene cap. Each pipette is packed in apolyethylene terephthalate/aluminium/low density polyethylene triplex bag.3 ml pipette containing 1 ml of solution.Box containing 1 pipette.
- White polypropylene pipette closed with a polyethylene cap. Each pipette is packed in a polyethylene terephthalate/aluminium/low density polyethylene triplex bag. 3 ml pipette containing 1 ml of solution. Box containing 3 pipettes.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
- TAD Pharma GmbH
- KRKA tovarna zdravil d.d. Novo mesto
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V490986
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0439/002
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Czechia
-
Estonia
-
France
-
Germany
-
Hungary
-
Italy
-
Latvia
-
Lithuania
-
Netherlands
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Labelling
This document does not exist in this language (English). You can find it
in another language below.